Bedel Financial Consulting, Inc. Zoetis Inc. Transaction History

Bedel Financial Consulting, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$155.97 - $200.09 $30,258 - $38,817	-194 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$181.39 - $234.03 $7,799 - $10,063	-43 Reduced 18.14%	194 $37,000
Q4 2021 Jan 11, 2022	BUY	$193.69 - $247.03 $12,783 - $16,303	66 Added 38.6%	237 $58,000
Q3 2021 Oct 12, 2021	SELL	$189.29 - $209.69 $18,929 - $20,969	-100 Reduced 36.9%	171 $33,000
Q2 2021 Aug 03, 2021	BUY	$155.9 - $187.99 $15,590 - $18,799	100 Added 58.48%	271 $51,000
Q2 2018 Jul 18, 2018	BUY	$79.9 - $89.2 $12,384 - $13,826	155 Added 968.75%	171 $15,000
Q1 2018 May 03, 2018	BUY	$71.51 - $84.69 $1,144 - $1,355	16 New	16 $1,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.